Berlin Heart® as a bridge to recovery
A systematic review analyzing nearly 1000 pediatric Berlin Heart® implants to describe the characteristics of patients who achieved successful explantation.
Surgical Risk Assessment in Aortic Dissection: The New German Tool
Validation of the perioperative risk prediction system for patients undergoing type A aortic dissection repair derived from the GERAADA German registry.
Cardiac Surgery Following TAVI: Confirming Concerning Outcomes
A retrospective analysis was conducted to evaluate the evolution and outcomes of cardiac surgery in patients with prior TAVI, utilizing data from the STS database from 2012 to 2023.
A review of myocardial protection in cardiac surgery: a retrospective since 2020
This literature review revisits the pathophysiological principles of ischemia, reperfusion, and myocardial ischemia tolerance, as well as the concepts of myocardial protectioN and the main evidence on outcomes among different cardioplegia solutions retrospectively since 2020.
PARTNER 3 at 5 Years: Low-Risk Patients and TAVI… Quo Vadimus?
Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
Mortality and Cost of Cardiac Stimulation Device Infections According to the Applied Treatment: Expert Commentary
Dr. Encarnación Gutiérrez’s review discusses the current state of managing infections associated with cardiac stimulation devices (CSDs), addressing the increase in associated costs due to three primary factors.
Rapid Growth in Thoracic Aortic Aneurysms: A Reliable Surgical Criterion?
A retrospective study conducted by Yale University over three decades scrutinizes the data from its Aortic Institute to assess the validity of surgical indications for rapid growth exceeding 3 mm/year.
Heparin-Induced Thrombocytopenia Following Cardiac Surgery: What Is the Real Impact?
A retrospective study conducted in the United States analyzed the incidence, outcomes, and costs associated with heparin-induced thrombocytopenia (HIT) in patients undergoing cardiac surgery.
